Mexico’s telecom regulator IFT has approved a plan to separate America Movil’s fixed-line Telmex and Telnor units as part of antitrust measures against the company. Creating a separate wholesale unit will allow Telmex to reinvest proceeds from line rentals in infrastructure upgrades, said the IFT. The company now has two years to carry out the functional separation of its retail and wholesale fixed-line businesses and will have to present an asset and debt transfer plan during that time, added the regulator in a statement.
In addition, the new fixed-line businesses will have to separate out local network services and have boards of directors independent of America Movil as well as brands that no longer use the names Telmex, Telnor or even Telcel, the company’s mobile brand.
American Movil replied that it would begin the separation process while challenging it in accordance with applicable laws. “The legal and functional separation plan ordered by the IFT today differs substantially with the plan presented by Telmex and Telnor,” said the company in a statement to the Mexican stock exchange.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas